Zobrazeno 1 - 10
of 258
pro vyhledávání: '"Gabrielle B, Rocque"'
Autor:
Catherine S. Smith BS, Nicole L. Henderson PhD, MPH, Emma K. Hendrix BS, Tanvi Padalkar BS, MA, Chao-Hui Sylvia Huang PhD, D’Ambra N. Dent MBA, Stacey A. Ingram MEd, Chelsea McGowan MPH, J. Nicholas Odom PhD, RN, Tara Kaufmann MD, MSCE, Bryan Weiner PhD, Doris Howell RN, PhD, Angela M. Stover PhD, Ethan Basch MD, Jennifer Young Pierce MD, MPH, Gabrielle B. Rocque MD, MSPH
Publikováno v:
Cancer Control, Vol 31 (2024)
Introduction Remote symptom monitoring (RSM) allows patients to electronically self-report symptoms to their healthcare team for individual management. Clinical trials have demonstrated overarching benefits; however, little is known regarding patient
Externí odkaz:
https://doaj.org/article/40c99a87f24b47f7b98013e25229f940
Autor:
Courtney P. Williams, Luqin Deng, Nicole E. Caston, Kathleen Gallagher, Rebekah Angove, Maria Pisu, Andres Azuero, Rebecca Arend, Gabrielle B. Rocque
Publikováno v:
Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)
Abstract Background Though financial hardship is a well‐documented adverse effect of standard‐of‐care cancer treatment, little is known about out‐of‐pocket costs and their impact on patients participating in cancer clinical trials. This stu
Externí odkaz:
https://doaj.org/article/803365d59bc74bc186cbfb0e353b8f49
Autor:
Nicole Lynn Henderson, Courtney Andrews, Stacey A. Ingram, Lisa Zubkoff, Nadine Tung, Lynne I. Wagner, Lauren P. Wallner, Antonio Wolff, Gabrielle B. Rocque
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21490-21501 (2023)
Abstract Background Cancer recurrence after treatment is a concern for patients and oncologists alike. The movement towards treatment optimization, with trials testing less than the current standard of care (SoC), complicates this experience. Our obj
Externí odkaz:
https://doaj.org/article/f3a7e1a2cb864f02b99d57c0cd68d839
Autor:
James N. Dionne‐Odom, Erin E. Kent, Gabrielle B. Rocque, Andres Azuero, Erin R. Harrell, Shena Gazaway, Rhiannon D. Reed, Reed W. Bratches, Avery C. Bechthold, Kyungmi Lee, Frank Puga, Ellen Miller‐Sonet, Katherine A. Ornstein
Publikováno v:
Health Expectations, Vol 26, Iss 5, Pp 1965-1976 (2023)
Abstract Background We aimed to describe the roles and challenges of family caregivers involved in patients' cancer treatment decision‐making. Methods Family caregiver‐reported data were analyzed from a national survey conducted in the United Sta
Externí odkaz:
https://doaj.org/article/7026f3d450a542349d7f655818b6adeb
Autor:
Karen E. Schifferdecker, Rebecca L. Butcher, Genevra F. Murray, Kristin E. Knutzen, Nirav S. Kapadia, Gabriel A. Brooks, Garrett T. Wasp, Susan Eggly, Laura C. Hanson, Gabrielle B. Rocque, Amanda N. Perry, Amber E. Barnato
Publikováno v:
BMC Palliative Care, Vol 22, Iss 1, Pp 1-13 (2023)
Abstract Introduction Early access to specialty palliative care is associated with better quality of life, less intensive end-of-life treatment and improved outcomes for patients with advanced cancer. However, significant variation exists in implemen
Externí odkaz:
https://doaj.org/article/03cf338d63564027aec7e7cd50c841c7
Autor:
Gabrielle B. Rocque, J. Nicholas Dionne-Odom, Angela M. Stover, Casey L. Daniel, Andres Azuero, Chao-Hui Sylvia Huang, Stacey A. Ingram, Jeffrey A. Franks, Nicole E. Caston, D’ Ambra N. Dent, Ethan M. Basch, Bradford E. Jackson, Doris Howell, Bryan J. Weiner, Jennifer Young Pierce
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Symptoms in patients with advanced cancer are often inadequately captured during encounters with the healthcare team. Emerging evidence demonstrates that weekly electronic home-based patient-reported symptom monitoring with automa
Externí odkaz:
https://doaj.org/article/6f205d3cd7b245478074fce401fa4a2d
Autor:
Courtney Andrews, Timothy C. Childers, Kimberly D. Wiseman, Valerie Lawhon, Stacey Ingram, Mary Lou Smith, Antonio C. Wolff, Lynne Wagner, Gabrielle B. Rocque
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background As the combination of systemic and targeted chemotherapies is associated with severe adverse side effects and long-term health complications, there is interest in reducing treatment intensity for patients with early-stage breast c
Externí odkaz:
https://doaj.org/article/60989516780d47b5b91098c1e668634e
Autor:
Nicole E. Caston, Valerie M. Lawhon, Karen Lisa Smith, Kathleen Gallagher, Rebekah Angove, Eric Anderson, Alan Balch, Andres Azuero, Chao‐Hui Sylvia Huang, Gabrielle B. Rocque
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8854-8865 (2021)
Abstract Background Given the high risk of COVID‐19 mortality, patients with cancer may be vulnerable to fear of COVID‐19, adverse psychological outcomes, and health care delays. Methods This longitudinal study surveyed the pandemic's impact on p
Externí odkaz:
https://doaj.org/article/c99897bdc79745c8a8c23a27661fc484
Autor:
Gabrielle B. Rocque, Courtney P. Williams, Courtney Andrews, Timothy C. Childers, Kimberly D. Wiseman, Kathleen Gallagher, Nadine Tung, Alan Balch, Valerie M Lawhon, Stacey A Ingram, Thelma Brown, Tara Kaufmann, Mary L. Smith, Angela DeMichele, Antonio C. Wolff, Lynne Wagner
Publikováno v:
Cancer Medicine, Vol 10, Iss 10, Pp 3288-3298 (2021)
Abstract Background Given excellent survival outcomes in breast cancer, there is interest in de‐escalating the amount of chemotherapy delivered to patients. This approach may be of even greater importance in the setting of the COVID‐19 pandemic.
Externí odkaz:
https://doaj.org/article/0b28efee115d42d19ee48a741f43b522
Autor:
Erica M. Stringer-Reasor, Jori E. May, Eva Olariu, Valerie Caterinicchia, Yufeng Li, Dongquan Chen, Deborah L. Della Manna, Gabrielle B. Rocque, Christos Vaklavas, Carla I. Falkson, Lisle M. Nabell, Edward P. Acosta, Andres Forero-Torres, Eddy S. Yang
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-12 (2021)
Abstract Background Poly (ADP-ribose)-polymerase inhibitors (PARPi) have been approved for cancer patients with germline BRCA1/2 (gBRCA1/2) mutations, and efforts to expand the utility of PARPi beyond BRCA1/2 are ongoing. In preclinical models of tri
Externí odkaz:
https://doaj.org/article/73538d58c45c449bae948e795b13f120